Lorlak

Lorlak ATC Classification

lorlatinib

Manufacturer:

Pfizer

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

ATC Classification

L01ED05 - lorlatinib ; Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Register or sign in to continue

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in

Register or sign in to continue

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in